Bernhard Gentner
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- RNA Interference and Gene Delivery 23
- CRISPR and Genetic Engineering 14
-
- MicroRNA in disease regulation 18
- Co-authors
- Luigi Naldini (48 shared papers)Mario Amendola (5 shared papers)Roberta Mazzieri (5 shared papers)Erika Zonari (12 shared papers)Brian D. Brown (2 shared papers)Davide Moi (3 shared papers)Ferdinando Pucci (3 shared papers)Alice Giustacchini (6 shared papers)
- Journals
- Blood (16 papers)Molecular Therapy (5 papers)Annals of Oncology (4 papers)Science Translational Medicine (3 papers)EMBO Molecular Medicine (3 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Bernhard Gentner
75 papers receiving 4.2k citations
Bernhard Gentner's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 1.1k
- Immunology 922
- Oncology 1.1k
- Molecular Biology 2.7k
- Genetics 1.0k
Countries citing papers authored by Bernhard Gentner
This map shows the geographic impact of Bernhard Gentner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Gentner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Gentner more than expected).
Fields of papers citing papers by Bernhard Gentner
This network shows the impact of papers produced by Bernhard Gentner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Gentner. The network helps show where Bernhard Gentner may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernhard Gentner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells Hit paper breakdown → | 2011 | 519 |
| 2 | 2007 | 476 | |
| 3 | Targeted genome editing in human repopulating haematopoietic stem cells Hit paper breakdown → | 2014 | 451 |
| 4 | 2013 | 302 | |
| 5 | 2008 | 261 | |
| 6 | 2010 | 172 | |
| 7 | 2012 | 168 | |
| 8 | 2012 | 162 | |
| 9 | 2003 | 160 | |
| 10 | 2013 | 124 | |
| 11 | 2017 | 120 | |
| 12 | Genotoxic effects of base and prime editing in human hematopoietic stem cells Hit paper breakdown → | 2023 | 114 |
| 13 | 2013 | 108 | |
| 14 | 2014 | 97 | |
| 15 | 2018 | 80 | |
| 16 | 2009 | 76 | |
| 17 | 2017 | 56 | |
| 18 | 2010 | 53 | |
| 19 | 2016 | 53 | |
| 20 | 2014 | 50 |
About Bernhard Gentner
Bernhard Gentner is a scholar working on Molecular Biology, Cancer Research, Genetics, Immunology and Oncology, having authored 82 papers that have together received 4.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (23 papers), Virus-based gene therapy research (20 papers), MicroRNA in disease regulation (18 papers), CAR-T cell therapy research (14 papers), CRISPR and Genetic Engineering (14 papers), Immune cells in cancer (12 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (922 citations), Oncology (1.1k citations), Molecular Biology (2.7k citations) and Genetics (1.0k citations). Bernhard Gentner has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Luigi Naldini, Mario Amendola, Roberta Mazzieri, Erika Zonari, Brian D. Brown, Davide Moi, Ferdinando Pucci, Alice Giustacchini, Letterio S. Politi and Anna Ranghetti. Their work appears in journals such as Blood, Molecular Therapy, Annals of Oncology, Science Translational Medicine and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.